Abstract
This report described the efficacy of NA inhibitors against newly evolved strains of H1N1 viruses. This in silico study was designed to understand the mode of interactions of NA inhibitors with NA. Hence, ligand, oseltamivir, zanamivir and peramivir were docked with modeled NA, ACD65204 (USA/2007), BAA06717 (Japan/1992), ACE77988 (S. Korea/2005) and ACD65204 (USA/2007). This study is based on interaction energies. Ramachandran Z-scores for these modeled structures were found to be −0.998, −1.121, −0.870 and −1.023, respectively, which confirms the accuracy of the modeled structures. These interactions revealed that some of these interacting residues have remained conserved throughout all the pandemics. These amino acid residues were found to be R118, R152, R225, E277, E278, R293 and Y402. Moreover, our study concludes that peramivir is the most efficient inhibitor against NA of H1N1.
References
Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, Gubareva LV, Deyde V, Garten RJ, Harris M, Gerber S, Vagasky S, Smith F, Pascoe N, Martin K, Dufficy D, Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS and Finelli L (2009) Triple-reassortant swine influenza A (H1) in humans in the United States, 2005–2009 N Engl J Med 360:2616–2625
Schulze IT (1972) The structure of influenza virus. II. A model based on the morphology and composition of subviral particles. Virology 47:181–196
Lamb RA and Choppin PW (1983) The structure and replication of influenza virus. Ann Rev Biochem 52: 467–506
Anwar T and Khan AU (2006) Matrix protein 1: A comparative in silico study on different strains of influenza A H5N1 Virus. Bioinformation 1:253–256
Webster RG, Bean WJ, Gorman OT, Chambers TM and Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56:152–179
Abed Y and Boivin G (2006) Treatment of respiratory virus infections. Antiviral Res 70:1–16
DeGoey DA, Chen HJ, Flosi WJ, Grampovnik DJ, Yeung CM, Klein LL and Kempf DJ (2002) Enantioselective synthesis of antiinfluenza compound A-315675. J Org Chem 67:5445–5453
Kati WM, Montgomery D, Carrick R, Gubareva L, Maring C, McDaniel K, Steffy K, Molla A, Hayden F, Kempf D and Kohlbrenner W (2002) In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication. Antimicrob Agents Chemother 46:1014–1021
Hayden FG, (1997) Antivirals for pandemic influenza. J Infect Dis 176Suppl 1:S56–61
Ison MG, Gubareva LV, Atmar RL, Treanor J and Hayden FG (2006) Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis 193:760–764
Normile D and Enserink M (2007) Avian influenza. With change in the seasons, bird flu returns. Science 315:448
Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y and Kawaoka Y (2005) Avian flu: isolation of drug-resistant H5N1 virus. Nature 437:1108
Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195–201
Laskowski RA, Chistyakov VV and Thornton JM (2005) PDBsum more: new summaries and analyses of the known 3D structures of proteins and nucleic acids. Nucleic Acids Res 33 (Database issue):D266–268
Eisenberg DR, Lüthy R and Bowie JU (1997) [20] VERIFY3D: Assessment of protein models with three-dimensional profiles Meth Enzymol 277:396–404
Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI and Gubareva LV (2008) Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 52:3284–3292
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khan, A.U., Shakil, S. & Lal, S.K. Efficacy of neuraminidase (NA) inhibitors against H1N1 strains of different geographical regions: an in silico approach. Indian J Microbiol 49, 370–376 (2009). https://doi.org/10.1007/s12088-009-0065-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12088-009-0065-2